Literature DB >> 16448612

[Hepatic stellate cells: it's role in normal and pathological conditions].

M Sarem1, R Znaidak, M Macías, R Rey.   

Abstract

Hepatic fibrosis is a dynamic and sophisticatedly regulated wound healing response to chronic hepatocellular injury. This fibrotic process results from the accumulation of extracellular matrix (ECM) including collagen, proteoglycan, and adhesive glycoproteins which are principally produced by hepatic stellate cells (HSC), a mesenchymal cell type located between parenchymal cell plates and sinusoidal endothelial cells in the space of Disse. In physiological conditions, quiescent HSCs play important roles in the regulation of retinoid homeostasis and ECM remodeling by producing ECM components as well as metalloproteases and its inhibitor. However during hepatic fibrogenesis, HSCs are known to be activated or "transdifferentiated" to myofibroblast-like cells which play a pivotal role in ECM remodeling and hepatic blood flow regulation. Activation of HSC is now well established as the key process involved in the development of hepatic fibrosis. Both basic morphology and functions of HSCs in normal conditions and its role in pathological fibrosis will be discussed in this review.

Entities:  

Mesh:

Year:  2006        PMID: 16448612     DOI: 10.1157/13083906

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  12 in total

1.  Protein O glycosylation regulates activation of hepatic stellate cells.

Authors:  Xiao Fan; Song Chuan; Wei Hongshan
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

2.  Down-regulation of tTG expression by RNAi inhibits HSC proliferation and attenuates liver fibrosis.

Authors:  Gang Zhao; Zhi-Qi Zhang; Bin Zhang; Meng Luo; Yong-Wei Sun; Zhi-Yong Wu
Journal:  Int J Clin Exp Pathol       Date:  2011-06-12

3.  Long-term maintenance of a microfluidic 3D human liver sinusoid.

Authors:  Ljupcho Prodanov; Rohit Jindal; Shyam Sundhar Bale; Manjunath Hegde; William J McCarty; Inna Golberg; Abhinav Bhushan; Martin L Yarmush; Osman Berk Usta
Journal:  Biotechnol Bioeng       Date:  2015-08-26       Impact factor: 4.530

4.  Effect of all-trans retinoic acid on liver fibrosis induced by common bile duct ligation in rats.

Authors:  Hui Wang; Zili Dan; Haiyan Jiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

5.  Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase.

Authors:  Jiang-Feng Qiu; Zhi-Qi Zhang; Wei Chen; Zhi-Yong Wu
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

6.  Differential effects of high-fish oil and high-lard diets on cells and cytokines involved in the inflammatory process in rat insulin-sensitive tissues.

Authors:  Lillà Lionetti; Maria Pina Mollica; Raffaella Sica; Immacolata Donizzetti; Giorgio Gifuni; Angelica Pignalosa; Gina Cavaliere; Rosalba Putti
Journal:  Int J Mol Sci       Date:  2014-02-20       Impact factor: 5.923

7.  CUG-binding protein 1 regulates HSC activation and liver fibrogenesis.

Authors:  Xingxin Wu; Xudong Wu; Yuxiang Ma; Fenli Shao; Yang Tan; Tao Tan; Liyun Gu; Yang Zhou; Beicheng Sun; Yang Sun; Xuefeng Wu; Qiang Xu
Journal:  Nat Commun       Date:  2016-11-17       Impact factor: 14.919

8.  Carvedilol Attenuates the Progression of Hepatic Fibrosis Induced by Bile Duct Ligation.

Authors:  Xiaopeng Tian; Chunhong Zhao; Jinbo Guo; Shurui Xie; Fengrong Yin; Xiaoxia Huo; Xiaolan Zhang
Journal:  Biomed Res Int       Date:  2017-03-15       Impact factor: 3.411

Review 9.  The protective effect of bee venom on fibrosis causing inflammatory diseases.

Authors:  Woo-Ram Lee; Sok Cheon Pak; Kwan-Kyu Park
Journal:  Toxins (Basel)       Date:  2015-11-16       Impact factor: 4.546

10.  NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation.

Authors:  Haowen Qiao; Yu Zhou; Xingping Qin; Jing Cheng; Yun He; Yugang Jiang
Journal:  Stem Cells Int       Date:  2018-05-10       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.